Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,053 | -1,469 | -9,230 | -7,804 | -5,412 |
| Depreciation Amortization | 3 | 2 | 233 | 232 | 181 |
| Other Working Capital | 840 | 446 | 2,505 | 1,925 | 1,165 |
| Other Operating Activity | 1,754 | 800 | 5,163 | 4,435 | 3,198 |
| Operating Cash Flow | $-456 | $-221 | $-1,329 | $-1,212 | $-868 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 45 | N/A | 155 | 155 | 105 |
| Common Stock Issued | 350 | 350 | 1,257 | 1,072 | 1,072 |
| Other Financing Activity | 0 | 0 | -45 | -29 | -15 |
| Financing Cash Flow | $395 | $350 | $1,368 | $1,199 | $1,162 |
| Beginning Cash Position | 92 | 92 | 53 | 53 | 53 |
| End Cash Position | 31 | 221 | 92 | 40 | 347 |
| Net Cash Flow | $-61 | $129 | $39 | $-14 | $294 |
| Free Cash Flow | |||||
| Operating Cash Flow | -456 | -221 | -1,329 | -1,212 | -868 |
| Free Cash Flow | -456 | -221 | -1,329 | -1,212 | -868 |